O que significa “Limpar”?
O animal não carrega a mutação. Não desenvolverá a doença e não vai passar adiante.
Discover the benefits of a DNA test for Bardet-Biedl Syndrome 4 in dogs, a crucial tool for responsible pet owners. This genetic condition can lead to serious health issues, including obesity and vision problems. By identifying whether your dog carries the BBS4 mutation, you can take proactive steps to manage their health. Early detection through DNA testing allows for tailored care and informed breeding decisions. Ensure your furry friend lives a happy, healthy life by understanding their genetic risks. Invest in a reliable DNA test today to safeguard your dog's well-being. Learn more about Bardet-Biedl Syndrome 4 testing and its importance in canine health.
Bardet-Biedl Syndrome 4 (BBS4) in dogs is a genetic condition that can lead to a range of health issues, including obesity, vision problems, and kidney dysfunction. A DNA test for BBS4 helps identify carriers and affected individuals, allowing for informed breeding decisions. Early detection through genetic testing can improve management strategies and enhance the quality of life for affected dogs. Responsible breeders can use this information to reduce the prevalence of the syndrome in future generations. Overall, DNA testing plays a crucial role in canine health and well-being.
Este teste de DNA está incluído a partir do nosso pacote Basic - e também faz parte dos packs Basic, Standard, Advanced, Complete.
Ver pacotes de teste de DNA →Bardet-Biedl Syndrome 4 (BBS4) is a genetic disorder that affects various systems in the body of affected dogs. It is part of a group of conditions known as Bardet-Biedl Syndromes, which are characterized by a range of symptoms that can include obesity, retinal degeneration, polydactyly, and kidney abnormalities. This syndrome is caused by mutations in specific genes that play a critical role in cellular function and development.
BBS4 is linked to mutations in the BBS4 gene, which is responsible for encoding a protein involved in the functioning of cilia—tiny hair-like structures that project from the surface of cells. Cilia play a crucial role in various cellular processes, including signaling pathways that regulate growth and development. When mutations occur in the BBS4 gene, it can lead to improper functioning of these cilia, resulting in the clinical manifestations associated with the syndrome.
Dogs affected by Bardet-Biedl Syndrome 4 can exhibit a range of clinical signs. One of the most common symptoms is obesity, which may develop early in life and can be challenging to manage. Additionally, affected dogs often experience progressive retinal degeneration, leading to vision impairment or blindness. Other potential symptoms include polydactyly, where dogs may have extra toes, and various kidney abnormalities that can affect renal function.
Diagnosing Bardet-Biedl Syndrome 4 typically involves a combination of clinical evaluation and genetic testing. DNA testing can identify mutations in the BBS4 gene, confirming the diagnosis. This genetic test is a valuable tool for breeders and pet owners, as it can help determine whether a dog carries the genetic mutation associated with the syndrome, allowing for informed breeding decisions and management of affected animals.
Currently, there is no cure for Bardet-Biedl Syndrome 4, and management focuses on alleviating symptoms and improving the quality of life for affected dogs. Weight management through a balanced diet and regular exercise is crucial to combat obesity. Regular veterinary check-ups are essential for monitoring kidney function and addressing any eye-related issues that may arise due to retinal degeneration. Supportive care and early intervention can significantly enhance the well-being of dogs diagnosed with this condition.
Bardet-Biedl Syndrome 4 is a complex genetic disorder that poses various health challenges for affected dogs. Understanding the genetic basis, clinical signs, and management strategies is essential for owners and breeders to ensure the best possible care for these animals. Genetic testing plays a vital role in the early diagnosis and responsible breeding practices, ultimately contributing to the health and longevity of dogs at risk for this syndrome.
O animal não carrega a mutação. Não desenvolverá a doença e não vai passar adiante.
Não. O animal é geralmente saudável, mas pode transmitir a mutação ao seu descendência.
Ele carrega duas cópias mutadas. Os sinais clínicos são esperados dependendo a doença. Não deveria ser criado.
Algumas doenças estão ligadas ao sexo, pelo que a sua expressão varia dependendo do sexo do animal.
This DNA test detects the mutation associated with Bardet-Biedl Syndrome 4 in order to identify clear, carrier, or at-risk animals.
Os testes de DNA ajudam os criadores a planejar acasalamentos mais seguros e a reduzir o risco de transmissão da mutação aos descendentes.
O modo de herança relatado para este teste é Autossômico Recessivo.
This test analyses the mutation BBS4 c.58A>T.
Não necessariamente. A interpretação depende do padrão de herança e do genótipo resultante.
Chew Tracy, Haase Bianca, Bathgate Roslyn, Willet Cali E, Kaukonen Maria K, Mascord Lisa J, Lohi Hannes T, Wade Claire M. A Coding Variant in the Gene Bardet-Biedl Syndrome 4 (BBS4) Is Associated with a Novel Form of Canine Progressive Retinal Atrophy. G3 (Bethesda). 2017 Jul 5;7(7):2327-2335. doi: 10.1534/g3.117.043109.
Sua privacidade, sua escolha
Usamos cookies essenciais para operar o site. Cookies opcionais (como provedores de conteúdo incorporados) estão desabilitados por padrão e só são habilitados se você concordar. Você pode alterar sua escolha a qualquer momento através do botão “Cookies”.
Necessário para recursos básicos e segurança. Sempre habilitado.
Melhora recursos como salvamento de preferências ou incorporações não publicitárias.
Ajuda-nos a entender o uso do site. Desativado por padrão.
Publicidade/rastreamento em sites (algumas incorporações de vídeos/mapas). Desativado por padrão.